A presidential advisory panel on Tuesday recommended new steps to speed the development of life-saving medicines, including the creation of a new industry-academic collaboration to identify and resolve bottlenecks in the scientific pipeline.
This content is available exclusively to Chronicle subscribers
Already a subscriber?
Log in now
Not a subscriber yet?
Subscribe now for instant access to this article and thousands of others, data tables, and interactive charts — all available exclusively for Chronicle subscribers. Plus your subscription includes weekly print or digital delivery of The Chronicle and The Review and the Chronicle iPad® Edition.Subscribe Today